Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P9903A
Product Details
HY-P9903A

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
Application
Cancer-programmed cell death
CAS
946414-94-4

Menu

Settings